Cargando…
Sirolimus-Induced Rash in a Kidney Transplant Patient
Sirolimus is an inhibitor of the mammalian target of rapamycin, which is used in kidney transplant immunosuppression. The clinical spectrum of cutaneous adverse events associated with sirolimus use varies, with maculopapular rash being an uncommon side effect very rarely reported in the literature....
Autores principales: | Bruss, Zachary, Farook, Shanza, Shah, Sana, Baker Sheikh, Abu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9586500/ https://www.ncbi.nlm.nih.gov/pubmed/36299840 http://dx.doi.org/10.12890/2022_003565 |
Ejemplares similares
-
Drug Interaction between Sirolimus and Ranolazine in a Kidney Transplant Patient
por: Masters, Joanna C., et al.
Publicado: (2014) -
Autophagy in kidney transplants of sirolimus treated recipients
por: Bhayana, Sagar, et al.
Publicado: (2017) -
Middle Meningeal Artery Embolization: A Paradigm Shift in Approach of Chronic Subdural Hematoma
por: Hanif, Hamza, et al.
Publicado: (2022) -
Sirolimus effects on cancer incidence after kidney transplantation: a meta-analysis
por: Yanik, Elizabeth L, et al.
Publicado: (2015) -
Conversion to Sirolimus Therapy in Kidney Transplant Recipients with New Onset Diabetes Mellitus after Transplantation
por: Veroux, Massimiliano, et al.
Publicado: (2013)